Eli Lilly has unveiled a new partnership with diabetes device maker Dexcom to breathe new life into its diabetes division. The deal will see Dexcom’s continuous glucose monitors integrated into Lilly’s Connected Diabetes Ecosystem – a portfolio of diabetes devices including smart-pens,…
Experimental opioid digital pill successful in early trial
Another ‘digital pill’ that tracks adherence to a common opioid could be on its way to market thanks to a successful initial feasibility study. Earlier this month, the FDA approved the first-ever digital pill in the form of Otsuka…
Amazon more interested in shipping medical devices… for now
Amazon is setting its sights on shipping medical devices rather than pharmaceuticals – at least for the time being. Earlier this year, rumours of the retail giant’s imminent entry into the medicines market arose after news broke that it had…
Samsung Bioepis’ trastuzumab biosimilar gets EC approval for breast cancer
The European Commission (EC) has approved Samsung Bioepis’ Ontruzant, a biosimilar version of Genentech’s Herceptin (trastuzumab), for the treatment of breast cancer in early and metastatic stages and also for metastatic gastric cancer. Trastuzumab, which is a monoclonal antibody, is…
Microsoft starts to support clinical trials
Technology leader Microsoft has entered into a partnership with the life sciences consulting firm Parexel. This is to develop software capable of accelerating drug development for clinical trials. The partnership will utilize Microsoft’s Azure cloud computing platform. With this system,…
Alzheimer’s Disease Drug Fast Tracked by FDA
The FDA has given Fast Track Designation to an Alzheimer’s disease (AD) clinical drug that targets an underlying—and often untreated—pathology of the disease. Biopharmaceutical company Alzheon Inc.’s lead clinical investigational drug ALZ-801, a novel, oral anti-amyloid optimized prodrug of tramiprosate,…
CDSCO making Clinical Trial Application Easy and Online – SUGAM Update
CDSCO has organised the workshop on hands on training/demonstration on POST APPROVAL SUBMISSION at CDSCO (HQ) on 17/11/2017. In the workshop DCGI officials has given the live demonstration of filing the following applications for Global Clinical Trials (GCT) 1. Major…
With INR 1,272,391 treatment for 100 days FDA approves Merck drug to prevent post-transplant infections
The FDA has approved a new Merck & Co drug to prevent infections in patients who have had stem cell transplants. Cytomegalovirus (CMV) infection can cause major complications after stem cell transplants, and while there are already antiviral treatments available,…
Shire CEO backs outcomes-based deals in rare diseases
Rare disease firms will increasingly use payment schemes where health systems are only charged when drugs work, the CEO of specialist pharma Shire has said. Under the leadership of CEO Flemming Ornskov, Shire has transformed itself into the leader in rare…
Wearable Tech Emerging For Chronic Pain Relief
The opioid crisis has revealed another real ongoing problem: a lot of people have chronic pain. For example, Lady Gaga recently revealed that she suffers from fibromyalgia, a chronic pain condition that the Centers for Disease Control and Prevention…
